Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,767 public trials 650 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity trial results

Completed

Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis

NCT03903822

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Clinical Research Center of Alabama, LLC Birmingham, Alabama, United States
  • Center for Dermatology and Plastic Surgery/CCT Scottsdale, Arizona, United States
  • Center for Dermatology and Plastic Surgery Scottsdale, Arizona, United States
  • California Dermatology & Clinical Research Institute Encinitas, California, United States
View all 76 locations
View Trial Details
Completed

Effect of the GSK2245035 on the Allergen-induced Asthmatic Response

NCT02833974

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Frankfurt am Main, Hesse, Germany
  • GSK Investigational Site Wiesbaden, Hesse, Germany
  • GSK Investigational Site Hanover, Lower Saxony, Germany
  • GSK Investigational Site Großhansdorf, Schleswig-Holstein, Germany
View Trial Details
Completed

An Open-label Study to Evaluate Correct Use and Ease of Use of the ELLIPTA DPI in Pediatric Subjects With Asthma

NCT03478657

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Huntington Beach, California, United States
  • GSK Investigational Site Napa, California, United States
  • GSK Investigational Site Aventura, Florida, United States
View all 19 locations
View Trial Details
Completed

A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma

NCT02924688

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Montgomery, Alabama, United States
  • GSK Investigational Site Gilbert, Arizona, United States
View all 409 locations
View Trial Details
Completed

A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Intravenous (IV) Dose of GSK2831781 in Healthy Volunteers and Patients With Plaque Psoriasis

NCT02195349

Conditions
Hypersensitivity, Hypersensitivity, Delayed, Immune System Diseases, +4 more
Locations
  • GSK Investigational Site Bonn, North Rhine-Westphalia, Germany
  • GSK Investigational Site Berlin, Germany
  • GSK Investigational Site London, United Kingdom
View Trial Details

Related conditions